Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study

References

• Janoff EN, Musher DM. Streptococcus pneumonia. In: Bennet JE, Dolin R, Blaser MJ, editors. Principles and Practice of Infectious Diseases. 8th ed. Philadelphia: Elsevier, 2015:2310-27.
   Google Scholar
• Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, McGeer A, Farley MM, Vugia DJ, Lexau C, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000; 90:223-9; PMID:10667183; http://dx.doi.org/10.2105/AJPH.90.2.223
   PubMed Web of Science ®Google Scholar
• Jackson LA, Neuzil KM, Yu O, Benson P, Barlow WE, Adams AL, Hanson CA, Mahoney LD, Shay DK, Thompson WW. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003; 348:1747-55; PMID:12724480; http://dx.doi.org/10.1056/NEJMoa022678
   PubMed Web of Science ®Google Scholar
• Farr BM, Johnston L, Cobb DK, Fisch MJ, Germanson TP, Adal KA, Anglim AM. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med 1995; 155:2336-40; PMID:7487259; http://dx.doi.org/10.1001/archinte.1995.00430210086013
   PubMed Web of Science ®Google Scholar
• Domínguez A, Salleras L, Fedson DS, Izquierdo C, Ruiz L, Ciruela P, Fenoll A, Casal J. Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study. Clin Infect Dis 2005; 40:1250-7; http://dx.doi.org/10.1086/429236
   PubMed Web of Science ®Google Scholar
• Domínguez A, Izquierdo C, Salleras L, Ruiz L, Sousa D, Bayas JM, Nebot M, Varona W, Celorrio JM, Carratalà J, et al. Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly. Eur Resp J 2010; 36:608-14; http://dx.doi.org/10.1183/09031936.00171309
   PubMed Web of Science ®Google Scholar
• Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, Leinonen M, Lindblad I, Sundelöf B, Kalin M. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 1998; 351:399-403; PMID:9482293; http://dx.doi.org/10.1016/S0140-6736(97)07358-3
   PubMed Web of Science ®Google Scholar
• Honkanen PO, Keistinen T, Miettinen L, Herva E, Sankilampi U, Läärä E, Leinonen M, Kivelä SL, Mäkelä PH. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999; 17:2493-500; PMID:10418894; http://dx.doi.org/10.1016/S0264-410X(99)00069-9
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C; EVAN Study Group. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study. Clin Infect Dis 2006; 43:860-8; http://dx.doi.org/10.1086/507340
   PubMed Web of Science ®Google Scholar
• Mykietiuk A, Carratalà J, Domínguez A, Manzur A, Fernández-Sabé N, Dorca J, Tubau F, Manresa F, Gudiol F. Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbil 2006; 25:457-62; http://dx.doi.org/10.1007/s10096-006-0161-8
   Google Scholar
• Christenson B, Hedlund J, Lundbergh P, Örqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Resp J 2004; 23:363-8; http://dx.doi.org/10.1183/09031936.04.00063504
   PubMed Web of Science ®Google Scholar
• Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17 (Suppl 1): S91-S93; PMID:10471189; http://dx.doi.org/10.1016/S0264-410X(99)00114-0]
   PubMedGoogle Scholar
• World Health Organization. Pneumococcal vaccines. WHO position paper -2012. Wkly Epidemiol Rec 2012; 87:129-44.
   PubMedGoogle Scholar
• Smith KJ, Zimmerman RK, Lin CJ, Nowalk MP, Ko F-S, Mcellister MC, Roberts MS. Alternative strategies for adult pneumococcal polysaccharide vaccination: a cost-effectiveness analysis. Vaccine 2008; 26:1420-31; PMID:18272262; http://dx.doi.org/10.1016/j.vaccine.2008.01.007
   PubMed Web of Science ®Google Scholar
• Wroe PC, Finkelstein JA, Ray GT, Linder JA, Johnson KM, Rifas-Shiman S, Moore MR, Huang SS . Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis 2012; 205:1589-92; PMID:22448012; http://dx.doi.org/10.1093/infdis/jis240
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Washington D.C. Public Health Foundation. Appendix A: Schedules and Recommendations. Recommended Adult Immunization Schedule. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/A/adult.pdf, 2015
   Google Scholar
• Pebody RG, Leino T, Nohynek H, Hellenbrand W, Salmaso S, Ruutu P. Pneumococcal vaccination policy in Europe. Euro Surveill 2005; 10:174-8; PMID:16280609.
   PubMedGoogle Scholar
• Tomczyk S, Bennet NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2014; 63:822-5.
   PubMed Web of Science ®Google Scholar
• Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson P, Gault S, van Werkhoven CH, van Deursen AMM, Sanders EAM, Verheij TJM, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372:1114-25; PMID:25785969; http://dx.doi.org/10.1056/NEJMoa1408544
   PubMed Web of Science ®Google Scholar
• Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members. Clin Infect Dis 2008; 47:989-96; PMID:18781875; http://dx.doi.org/10.1086/591966
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Ester F, Sarrá N, Ansa X, Saún N; EVAN Study Group. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006; 6:231; http://dx.doi.org/10.1186/1471-2458-6-231
   PubMed Web of Science ®Google Scholar
• Marès Bermúdez J, van Esso Arbolave D, Arístegui Fernández J, Ruiz Contreras J, González Hachero J, Merino Moína M, Barrio Corrales F, Álvarez García FJ, Cilleruelo Ortega MJ, Ortigosa del Castillo L, Moreno Pérez D. Vaccination schedule of the Spanish Association of Pediatrics: Recommendations 2010. An Pediatr 2010; 72:433.e1-17
   Google Scholar
• Ciruela P, Soldevila N, Hernández S, Selva L, de Sevilla MF, García- García JJ, Planes AM, Muñoz-Almagro C, Domínguez A; the Microbiological Reporting System of Catalonia Study Group. Risk factors for invasive pneumococcal disease in a community with a high proportion of non-vaccine serotypes. Vaccine 2013; 31:960-6; PMID:23261046; http://dx.doi.org/10.1016/j.vaccine.2012.11.102
   PubMed Web of Science ®Google Scholar
• Fenoll A, Granizo JJ, Giménez MJ, Yuste J, Aguilar L. Secular trends (1990-2013) in serotypes and associated non-susceptibility of S. pneumoniae isolates causing invasive disease in the pre/post-era of pneumococcal conjugate vaccines in Spanish regions without universal pediatric pneumococcal vaccinations. Vaccine 2015; 33:5691-9; PMID:26341563; http://dx.doi.org/10.1016/j.vaccine.2015.08.009
   PubMed Web of Science ®Google Scholar
• Sangil A, Xercavins M, Rodríguez-Carballeira M, Andrés M, Riera M, Espejo E, Pérez J, Garau J, Calbo E. Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed. J Infection 2015; 71:422-7; http://dx.doi.org/10.1016/j.jinf.2015.07.004
   PubMed Web of Science ®Google Scholar
• Burgos J, Falcó V, Borrego A, Sordé R, Larrosa MN, Martínez X, Planes AM, Sánchez A, Palomar M, Rello J, Pahissa A. Impact of the emergence on non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect 2012; 19:385-91; PMID:22583156; http://dx.doi.org/10.1111/j.1469-0691.2012.03895.x
   PubMed Web of Science ®Google Scholar
• Guevara M, Ezpeleta C, Gil- Setas A, Torroba L, Beristain X, Aguinaga A, García-Irure JJ, Navascués A, García-Cenoz M, Castilla J; Working Group for Surveillance of the Pneumococcal Disease in Navarre. Vaccine 2014; 32:2553-62; PMID:24674661; http://dx.doi.org/10.1016/j.vaccine.2014.03.054
   PubMed Web of Science ®Google Scholar
• McBean AM, Jung K, Hebert PL. Decreasing invasive pneumococcal disease in the elderly: A state-level analysis. Vaccine 2006; 24:5609-14; PMID:16725240; http://dx.doi.org/10.1016/j.vaccine.2006.04.055
   PubMed Web of Science ®Google Scholar
• Moore MR, Gelles RL, Schaffners W, Lynfield R, Lexau C, Bennet NM, Petit S, Zansky SM, Harrison LH, Reingold A, et al. Effect of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis 2015; 15:301-9; PMID:25656600; http://dx.doi.org/10.1016/S1473-3099(14)71081-3
   PubMed Web of Science ®Google Scholar
• Waight PA, Andrews NJ, Ladhani SN, Sheppard CL, Slack MPE, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis 2015; 15:629; PMID:26008826; http://dx.doi.org/10.1016/S1473-3099(15)70044-7
   PubMed Web of Science ®Google Scholar
• Menzies RI, Jardine A, McIntyre PB. Pneumonia in elderly Australians: reduction in presumptive pneumococcal hospitalizations but no change in all cause pneumonia hospitalization following 7-valent pneumococcal conjugate vaccination. Clin Infect Dis 2015; 61:927-33; PMID:26066319; http://dx.doi.org/10.1093/cid/civ429
   PubMed Web of Science ®Google Scholar
• Shigayeva A, Rudnick W, Green K, Tyrrell G, Demczuck WH, Gold WL, Gubbay J, Jamieson F, Plevneshi A, Pong-Porter S, et al. Association of serotype with respiratory presentation of pneumococcal infection, Ontario, Canada, 2003-2011. Vaccine 2016; 34:846-53; PMID:26602266; http://dx.doi.org/10.1016/j.vaccine.2015.11.021
   Google Scholar
• Regev-Yochay G, Paran Y, Bishara J, Oren I, Chowers M, Tziba Y, Istomin V, Weinberger M, Miron D, Temper V et al. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study. Vaccine 2015; 32:1135-42; http://dx.doi.org/10.1016/j.vaccine.2015.01.030
   Web of Science ®Google Scholar
• Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, Levine OS, Whitney CG, O'Brien KL, Moore MT, the Serotype Replacement Study Group. Plos Med 2013; 10:e1001517.
   PubMed Web of Science ®Google Scholar
• Steens A, Bergsaker MA, Aaberge IS, Ronning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 2013; 31:6232-8; PMID:24176490; http://dx.doi.org/10.1016/j.vaccine.2013.10.032
   PubMed Web of Science ®Google Scholar
• Harboe ZB, Dalby T, Weinberger DM, Benfield T, Molbak T, Slotved HC, Suppli CH, Konradsen HB, Valentiner-Branth P. Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. Clin Infect Dis 2014; 59:1066-73; PMID:25034421; http://dx.doi.org/10.1093/cid/ciu524
   PubMed Web of Science ®Google Scholar
• Ochoa-Gondar O, Gómez-Bertomeu F, Vila- Córcoles A, Raga X, Aguirre C, Utrera J, de Diego C, Guzmám JA, Figuerola E; Grupo de Estudio EPIVAC. Prevalence of serotypes causing invasive pneumococcal disease in the region of Tarragona, Spain, 2006-2009: vaccine serotype coverage for the distinct anti-pneumococcal vaccine formulations. [In Spanish]. Rev Esp Quimother 2015; 28:29-35
   PubMed Web of Science ®Google Scholar
• Ardanuy C, Marimón JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallarés R, Pérez-Trallero E, Liñares J. Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): Implications for future vaccination strategies. Plos One 2012; 7: e43619; PMID:22928005; http://dx.doi.org/10.1371/journal.pone.0043619
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolomé R, Sauca G, Gallés C, Morta M, Ballester F, et al. Serotypes and clones causing invasive pneumococcal disease beforee and after the use of new conjugate vaccines in Catalonia, Spain. J Infection 2011; 63:151-62; http://dx.doi.org/10.1016/j.jinf.2011.06.002
   PubMed Web of Science ®Google Scholar
• US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People. 2020 Topics & Objectives. https://www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. US Department of Health and Human Services, Washington, United States 2015.
   Google Scholar
• Multack M, Flowers L. Racial and ethnic disparities in influenza and pneumococcal immunization rates among Medicare beneficiaries. AARP Public Policy Institute. Available from: http://www.aarp.org/content/dam/aarp/research/public_policy_institute/health/2011/racial-and-ethnic-disparities-in-immunization-rates-among-medicare-beneficiaries-AARP-ppi-health.pdf, 2012.
   Google Scholar
• Williams WW, Lu PJ, O'Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE. Vaccination coverage among adults, excluding influenza vaccination-United States, 2013. MMWR 2015; 64:95-102; PMID:25654611.
   PubMed Web of Science ®Google Scholar
• Al-Sukhni W, Avarino P, McArthur MA, McGeer A. Impact of public vaccination programs on adult vaccination rates: two examples from Ontario, Canada. Vaccine 2008; 26:1432-7; PMID:18272261; http://dx.doi.org/10.1016/j.vaccine.2008.01.001
   PubMed Web of Science ®Google Scholar
• Sabapathy D, Strong D, Myers R, Li B, Quan H. Pneumococcal vaccination of the elderly during visits to acute care providers: Who are vaccinated? Prev Med 2014; 62:155-60; PMID:24246965; http://dx.doi.org/10.1016/j.ypmed.2013.11.009
   PubMed Web of Science ®Google Scholar
• Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, Coleman B, Loeb M, Rubinstein E, McElhaney J, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health 2014; 14:442; PMID:24884433; http://dx.doi.org/10.1186/1471-2458-14-442
   PubMed Web of Science ®Google Scholar
• Schwartz AW, Clarfield AM, Doucettte JT, Valinsky L, Karpati T, Landrigan PJ, Sternberg SA. Disparities in pneumococcal and influenza immunization among older adults in Israel: A cross-sectional analysis of socio-demographic barriers to vaccination. Prev Med 2013; 56:337-40; PMID:23402962; http://dx.doi.org/10.1016/j.ypmed.2013.01.019
   PubMed Web of Science ®Google Scholar
• Ridda I, Motbey C, Lam L, Lindley IR, McIntyre PB, McIntyre CR. Factors associated with pneumococcal immunization among hospitalized elderly persons: a survey of patient's perception, attitude, and knowledge. Vaccine 2008; 26:234-40; PMID:18054818; http://dx.doi.org/10.1016/j.vaccine.2007.10.067
   PubMed Web of Science ®Google Scholar
• Dower J, Donald M, Begum N, Vlack S, Ozolins I. Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland, Australia. Vaccine 2011; 29:3031-7; PMID:21335033; http://dx.doi.org/10.1016/j.vaccine.2011.01.116
   PubMed Web of Science ®Google Scholar
• Yang TU, Song JY, Noh JY, Cheong HJ, Kim WJ. Influenza and pneumococcal vaccine coverage rates among patients admitted to a teaching hospital in South Korea. Infect Chemother 2015; 47:41-8; PMID:25844262; http://dx.doi.org/10.3947/ic.2015.47.1.41
   PubMed Web of Science ®Google Scholar
• Kryciak S, Liuu E, Vincenot M, Landelle C, Lesprit P, Cariot MA, Mézière A, Taillandier-Hériche E, Leroux JL, Canoui-Poitrine F, et al. Improvement in pneumococcal immunization coverage in older patients [Article in French]. Rev Med Intern 2015; 36:243-7
   PubMed Web of Science ®Google Scholar
• Loubet P, Kernéis S, Grogh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine 2015; 33:3703-8; PMID:26073016; http://dx.doi.org/10.1016/j.vaccine.2015.06.012
   PubMed Web of Science ®Google Scholar
• Arslan I, Beyazova U, Aksakal N, Polat S, Camurdan AD, Sahin F. New opportunities for vaccinating older people: Well-child clinic visits. Pediatr Int 2012; 54:45-51; PMID:21917062; http://dx.doi.org/10.1111/j.1442-200X.2011.03474.x
   PubMed Web of Science ®Google Scholar
• Satman I, Akalin S, Cakir B, Altinel S; DiaVax Study Group. The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey. Hum Vacc Immunother 2013; 9:2618-26; http://dx.doi.org/10.4161/hv.25826
   PubMed Web of Science ®Google Scholar
• Lu PJ, Nuorti P. Pneumococcal polysaccharide vaccination among adults aged 65 years and older, US, 1989-2008. Am J Prev Med 2010; 39:287-95; PMID:20837278; http://dx.doi.org/10.1016/j.amepre.2010.06.004
   PubMed Web of Science ®Google Scholar
• Lode H, Ludwig E, Kassianos G. Pneumococcal infection- low awareness as a potential barrier to vaccination: results of a European survey. Adv Ther 2013; 30:387-405; PMID:23605248; http://dx.doi.org/10.1007/s12325-013-0025-4
   PubMed Web of Science ®Google Scholar
• Liu S, Xu E, Liu Y, Xu Y, Wang J, Du J, Zhang X, Che X, Gu W. Factors associated with pneumococcal vaccination among an urban elderly population in China. Hum Vaccin Immunother 2014; 10:2994-9; PMID:25483646; http://dx.doi.org/10.4161/21645515.2014.972155
   PubMed Web of Science ®Google Scholar
• Godoy P, Castilla J, Mayoral JM, Martín V, Astray J, Torner N, Toledo D, Soldevila N, González-Candelas F, García S, et al. Influenza vaccination of primary healthcare physicians may be associated with vaccination of their patients: a vaccination coverage study. BMC Fam Pract 2015; 16:44; PMID:25880501; http://dx.doi.org/10.1186/s12875-015-0259-0
   PubMed Web of Science ®Google Scholar
• Carreño-Ibáñez LV, Esteban-Vasallo MD, Domínguez-Berjón MF, Astray-Mochales J, González del Yerro C, Iniesta-Fornies D, Gascón-Sancho MJ, Jiménez-García R. Coverage of and factors associated with pneumococcal vaccination in chronic obstructive pulmonary disease. Int J Tuber Lung Dis 2015; 19:735-41; http://dx.doi.org/10.5588/ijtld.14.0480
   PubMed Web of Science ®Google Scholar
• Aríñez-Fernández MC, Carrasco-Garrido P, García-Carballo M, Hernández-Barrera V, de Miguel A, Jiménez-García R. Determinants of pneumococcal vaccination among patients with chronic obstructive pulmonary disease in Spain. Hum Vacc 2006; 2:99-104; http://dx.doi.org/10.4161/hv.2756
   PubMed Web of Science ®Google Scholar
• World Health Organization. Regional Office for Europe: Strategy and action plan for healthy ageing in Europe, 2012-2020. Copenhagen, Denmark. Available from: http://www.euro.who.int/data/assets/pdffile/0008/175544/ RC62wd10Rev1-Eng.pdf, 2012.
   Google Scholar
• Fernández-Ruiz M, Mon Trotti V, Serrano Frontaura A, López-Medrano F. Knowledge and adherence to pneumococcal vaccination recommendations in adults among family physicians and hospital specialists.[In Spanish]. Enf Infecc Microbiol Clin 2012; 30:352-3; http://dx.doi.org/10.1016/j.eimc.2012.01.018
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Shone LP, Barth R, Kouides RW, Long C, Humiston SG, Jennings J, Bennett NM. Physician practices and attitudes regarding adult immunizations. Prev Med 2005; 40:152-61; PMID:15533524; http://dx.doi.org/10.1016/j.ypmed.2004.05.010
   PubMed Web of Science ®Google Scholar
• Lau D, Hu J, Majumdar SR, Storie DA, Rees SE, Johnson JA. Interventions to improve influenza and pneumococcal vaccination rates among community-dwelling adults: a systematic review and meta-analysis. Ann Fam Med 2012; 10:538-46; PMID:23149531; http://dx.doi.org/10.1370/afm.1405
   PubMed Web of Science ®Google Scholar
• Coyle CM, Currie BP. Improving the rates of inpatient pneumococcal vaccination: impact of standing orders versus computerized reminders to physicians. Infect Control Hosp Epidemiol 2004; 25:904-7; PMID:15566021; http://dx.doi.org/10.1086/502317
   PubMed Web of Science ®Google Scholar
• Arencibia M, Navarro JF, Delgado JA, Pérez G, López D, López P. Missed opportunities in anti-pneumococcal vaccination. Can something more be done for prevention? [In Spanish]. Arch Bronconeumol 2014; 50:93-8; http://dx.doi.org/10.1016/j.arbres.2013.09.016
   PubMed Web of Science ®Google Scholar
• Picazo JJ, González F, Salleras L, Bayas JM, Álvarez MJ. Survey of adult influenza and pneumococcal vaccination in Spain [In Spanish]. Vacunas 2012; 13:100-11. http://dx.doi.org/10.1016/S1576-9887(12)70048-1
   Google Scholar
• Andersen R, Newman JF. Societal and Individual Determinants of Medical Care Utilization in the United States. The Milbank Quarterly 2005; 83; http://dx.doi.org/10.1111/j.1468-0009.2005.00412.x
   Web of Science ®Google Scholar
• Chiatti C, Barbadoro P, Lamura G, Pennacchietti L, Di Stanislao F, D'Errico MM, Prospero E. Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional study. BMC Public Health 2011; 11:207; PMID:21457562; http://dx.doi.org/10.1186/1471-2458-11-207
   PubMed Web of Science ®Google Scholar
• Andersen RM. Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav 1995; 36:1-10; PMID:7738325; http://dx.doi.org/10.2307/2137284
   PubMed Web of Science ®Google Scholar
• Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14:61-65; PMID:14258950.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373-83; PMID:3558716; http://dx.doi.org/10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar